Serum PTH levels in dialysis: better safe than sorry

[1]  Z. Diao,et al.  Hemodialysis patients with low serum parathyroid hormone levels have a poorer prognosis than those with secondary hyperparathyroidism , 2020, Therapeutic advances in endocrinology and metabolism.

[2]  S. Eiam‐Ong,et al.  The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism , 2019, Renal failure.

[3]  M. Vervloet,et al.  Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome? , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  P. Evenepoel,et al.  Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease? , 2014, Seminars in nephrology.

[5]  L. Gesualdo,et al.  VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  C. Ronco,et al.  Mineral metabolism abnormalities and vitamin D receptor activation in cardiorenal syndromes , 2012, Heart Failure Reviews.

[7]  P. Messa,et al.  New insights into the role of calcium-sensing receptor activation. , 2011, Journal of nephrology.

[8]  John Cunningham,et al.  Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[9]  E. Brown,et al.  Physiology and pathophysiology of the calcium-sensing receptor in the kidney. , 2010, American journal of physiology. Renal physiology.

[10]  P. Messa,et al.  Pathophysiology of Calcium and Phosphate Metabolism Impairment in Chronic Kidney Disease , 2009, Blood Purification.

[11]  L. Quarles,et al.  Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics. , 2008, Kidney international.

[12]  F. Port,et al.  Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. , 2005, Kidney international.

[13]  Su-Chen Huang,et al.  Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  P. Fein,et al.  Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.